Quoted from http://www.businessweek.com/news/2010-12-07/actavis-said-to-pay-12-million-in-digitek-settlement.html
Actavis Said to Pay $12 Million in Digitek SettlementDecember 07, 2010, 2:31 PM EST
By Jef Feeley and Sophia Pearson
Dec. 7 (Bloomberg) -- Actavis Group hf, a maker of generic drugs, will pay at least $12 million to resolve claims that the company failed to warn consumers its Digitek heart drug was defective, according to people familiar with the settlement.
Officials of closely held Actavis agreed in September to set up a settlement fund to resolve as many as 3,000 lawsuits alleging the drugmaker misled consumers about Digitek, used to treat heart failure and abnormal heart rhythms, three people with direct knowledge of the settlement said. They spoke on the condition of anonymity because they weren’t authorized to speak publicly about the accord.
The settlement, which also covers suits against generic- drug maker Mylan Inc. over its marketing of Digitek, provides an average recovery of at least $4,000 each for consumers who took the defective drugs, the people said. Actavis and Mylan recalled Digitek in 2008 after finding some batches of the pills may have had double the amount of chemical they were supposed to contain.